Combined Synopsis/Solicitation for MHS GENESIS Bridge

The Defense Health Agency (DHA) is soliciting and negotiating with only one source, Leidos, Inc., for the MHS GENESIS Bridge project. The acquisition is being conducted under FAR Part 12, Acquisition of Commercial Products and Commercial Services, and FAR Subpart 6.3, Other Than Full and Open Competition. The project involves the provision of commercial products or commercial services. The period of performance is one year, with a six-month option. • The project is a combined synopsis/solicitation for commercial products or commercial services. • The acquisition is being conducted under FAR Part 12 and FAR Subpart 6.3. • The project involves the provision of commercial products or commercial services. • The period of performance is one year, with a six-month option.